🇺🇸 FDA
Patent

US 6884414

Recombinant influenza viruses expressing tumor-associated antigens as antitumor agents

expired A61KA61K2039/5256A61K2039/53

Quick answer

US patent 6884414 (Recombinant influenza viruses expressing tumor-associated antigens as antitumor agents) held by The United State of America as represented by the Department of Health and Human Services expires Mon Apr 21 2025 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United State of America as represented by the Department of Health and Human Services
Grant date
Tue Apr 26 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 21 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K2039/5256, A61K2039/53, A61P, A61P37/04